Board regularizes 2 directors, proposes name change and MOA alteration
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sattva Sukun Lifecare board approved regularization of Sachin Manseta (Non-Executive Independent) and Chirag Dedhia (Non-Executive Non-Independent) as directors for 5-year terms effective 22 July 2026, subject to shareholder approval. Board also approved changing the company name to Tavexia, Trumaxa, Trustarex, or Tradamex Lifecare Limited, and expanded the MOA object clause to include chemicals, pharmaceuticals, nutraceuticals, biotechnology, and CRO/CDMO/CRAMS services. EGM notice issued.
Name change and expanded business scope signal a strategic pivot. New directors bring legal and finance expertise. Awaiting shareholder and MCA approval.